Allegro Ophthalmics Preps for Phase III of Risuteganib

Dr. Allen C. HoПодробнее

Allegro OphthalmicsПодробнее

ASRS 2019 Street Team: Peter K. Kaiser, MDПодробнее

Allegro Plans for Phase III of LuminateПодробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019Подробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASRS 2019Подробнее

Allegro Ophthalmics: First-in-Class Anti-Integrin Agent (OIS@ASRS 2016)Подробнее

Allegro Ophthalmics Reports Phase II Data for LuminateПодробнее

ASRS 2020: Impact of baseline OCT on response to risuteganib for treatment of intermediate AMDПодробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019Подробнее

EURETINA: Zeiss concentrates on workflow enhancementsПодробнее

Novel advanced 3D neuro-imaging in the Angio Suite for faster treatment of ELVOsПодробнее

What is the therapeutic potential for a SPPARMα?Подробнее

New Frontiers: Manufacturing a Protein-Based Artificial Retina in Low Earth OrbitПодробнее

Transform your system to Philips AzurionПодробнее

Allegro Ophthalmics - OIS@AAO 2015Подробнее

Ophthalmology Innovator Stories: What Is Allegro Ophthalmics?Подробнее